European journal of nuclear medicine and molecular imaging
AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy.
Riccardo Laudicella, Antongiulio Faggiano, Valeria Pirro, Rexhep Durmo, Pierpaolo Salsi, Roberta Modica, Luca Urso, Chiara Maria Grana, Daniele Sances, Maria Rinzivillo, Manuela Albertelli, Francesca Spada, Stefano Partelli, Francesco Ferraù, Nicola Fazio
Published: 202510.1007/s00259-025-07596-2
Abstract
PURPOSE: Carcinoid syndrome (CS) is the most frequent neuroendocrine tumor (NET)-related syndrome with variable presentations related to hormonal discharge and long-term complications, such as carcinoid heart disease (CHD). Carcinoid crisis (CC) is a…
Preview only. Read the full abstract at the source